Superiority of long-acting to short-acting loop diuretics in the treatment of congestive heart failure.

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Circulation Journal

• Publication date

  2012-03-25

• Fields of study

  Medicine

• Identifiers
  DOI 10.1253/CIRCJ.CJ-11-1500PMID 22451450
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Guidelines for treatment of chronic heart failure

  2012cited by this paper
• Contemporary medical management of systolic heart failure.

  2012cited by this paper
• Eplerenone in Patients with Systolic Heart Failure and Mild Symptoms

  2011cited by this paper
• Eplerenone in patients with systolic heart failure and mild symptoms.

  2011cited by this paper
• Predictors of long-term adverse outcomes in elderly patients over 80 years hospitalized with heart failure. - A report from the Japanese Cardiac Registry of Heart Failure in Cardiology (JCARE-CARD)-.

  2011cited by this paper
• Interaction between loop diuretic-associated mortality and blood urea nitrogen concentration in chronic heart failure.

  2011cited by this paper
• Characteristics and outcomes of patients with heart failure in general practices and hospitals.

  2007cited by this paper
• Diuretic use, progressive heart failure, and death in patients in the DIG study.

  2006cited by this paper
• Guidelines for the diagnosis and treatment of Chronic Heart Failure: full text (update 2005) The Task Force for the diagnosis and treatment of CHF of the European Society of Cardiology

  2005cited by this paper
• Different effects of long- and short-acting loop diuretics on survival rate in Dahl high-salt heart failure model rats.

  2005cited by this paper
• Furosemide and the progression of left ventricular dysfunction in experimental heart failure.

  2004cited by this paper
• Differences between patients with a preserved and a depressed left ventricular function: a report from the EuroHeart Failure Survey.

  2004cited by this paper
• Low-dose carvedilol improves left ventricular function and reduces cardiovascular hospitalization in Japanese patients with chronic heart failure: the Multicenter Carvedilol Heart Failure Dose Assessment (MUCHA) trial.

  2004cited by this paper
• Corrigendum to ‘Efficacy and safety of oral candesartan cilexetil in patients with congestive heart failure’ [Eur J Heart Fail 5 (2003) 699–677]

  2004cited by this paper
• Diuretic use, progressive heart failure, and death in patients in the Studies Of Left Ventricular Dysfunction (SOLVD).

  2003cited by this paper
• Effects of pimobendan on adverse cardiac events and physical activities in patients with mild to moderate chronic heart failure: the effects of pimobendan on chronic heart failure study (EPOCH study).

  2002cited by this paper
• Torasemide in chronic heart failure: results of the TORIC study

  2002cited by this paper
• Effect of ramipril and furosemide treatment on interstitial remodeling in post-infarction heart failure rat hearts.

  2002cited by this paper
• Long-term trends in the incidence of and survival with heart failure.

  2002cited by this paper
• Guidelines for the diagnosis and treatment of chronic heart failure.

  2001cited by this paper
• Open-label randomized trial of torsemide compared with furosemide therapy for patients with heart failure.

  2001cited by this paper
• Healthcare Costs of Patients with Heart Failure Treated with Torasemide or Furosemide

  2000cited by this paper
• The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators.

  1999cited by this paper
• Congestive heart failure in the community: a study of all incident cases in Olmsted County, Minnesota, in 1991.

  1998cited by this paper
• Diuretic and vasodilating actions of torasemide.

  1994cited by this paper
• A comparison of sample size methods for the logrank statistic.

  1992cited by this paper
• Anti-aldosteronergic effect of torasemide.

  1991cited by this paper
• Acute vasoconstrictor response to intravenous furosemide in patients with chronic congestive heart failure. Activation of the neurohumoral axis.

  1985cited by this paper
• Clinical and pharmacological investigations of the new saluretic azosemid

  1978cited by this paper
• The natural history of congestive heart failure: the Framingham study.

  1971cited by this paper

• Metolazone and Azosemide, Clinically Utilized Diuretics, Exhibit Inhibitory Activity for Glyoxalase I

  2025cites this paper
• JCS/JHFS 2025 Guideline on Diagnosis and Treatment of Heart Failure.

  2025cites this paper
• JCS/JHFS 2025 Guideline on Diagnosis and Treatment of Heart Failure.

  2025cites this paper
• Syndromes cardiorénaux de type 1 et de type 2

  2024cites this paper
• Intravenous delivery of furosemide using lipid-based versus polymer-based nanocapsules: in vitro and in vivo studies

  2024cites this paper
• Use of short‐acting vs. long‐acting loop diuretics after heart failure hospitalization

  2022influential citation
• Sulfonamide Diuretic Azosemide as an Efficient Carbonic Anhydrase Inhibitor

  2022cites this paper
• Prognostic significance of cardiorenal dysfunction within 1 year after atrial fibrillation ablation in patients with systolic dysfunction

  2022cites this paper
• Predictors of bleeding events in acute decompensated heart failure patients with antithrombotic therapy: AURORA study

  2022cites this paper
• Management of heart failure with preserved ejection fraction: from neurohormonal antagonists to empagliflozin

  2022cites this paper
• Prognostic significance of diastolic dysfunction in patients with systolic dysfunction undergoing atrial fibrillation ablation

  2022cites this paper
• Ensemble learning application to discover new trypanothione synthetase inhibitors

  2021cites this paper
• Renoprotection by long‐term low‐dose tolvaptan in patients with heart failure and hyponatremia

  2021cites this paper
• Efficacy and safety of tolvaptan in acute heart failure patients during long-distance transportation.

  2021cites this paper
• Influence of polyvascular disease on clinical outcome in patients undergoing transcatheter aortic valve implantation via transfemoral access

  2021cites this paper
• Effect of Empagliflozin as an Add-On Therapy on Decongestion and Renal Function in Patients With Diabetes Hospitalized for Acute Decompensated Heart Failure

  2021cites this paper
• Tailoring the management of hypertension to comorbidities

  2021cites this paper
• Comparative effects of furosemide and other diuretics in the treatment of heart failure: a systematic review and combined meta-analysis of randomized controlled trials

  2020cites this paper
• Safety and Efficacy of Adding Dapagliflozin to Furosemide in Type 2 Diabetic Patients With Decompensated Heart Failure and Reduced Ejection Fraction

  2020cites this paper
• Safety and E�cacy of adding Dapagli�ozin to Furosemide in Type 2 Diabetic Patients with Decompensated Heart Failure and Reduced Ejection Fraction

  2020cites this paper
• Renoprotective effect of tolvaptan in patients with new‐onset acute heart failure

  2020cites this paper
• JCS 2017/JHFS 2017 Guideline on Diagnosis and Treatment of Acute and Chronic Heart Failure　- Digest Version.

  2019cites this paper
• Reduction in Left Ventricular Ejection Fraction is Associated with Subsequent Cardiac Events in Outpatients with Chronic Heart Failure

  2019cites this paper
• Patients With CONgestive Heart Failure Benefit From Long-Term Treatment Effects With Novel Treatment Using Azosemide Compared With Furosemide Derived From Existing Retrospective Study Data: CONTENTED.

  2019cites this paper
• The Effect of Diuretics on Patients with Heart Failure: A Network Meta-Analysis: Diuretics Effect on Heart Failure Patients.

  2019cites this paper
• [Heart failure in patients over 80 years old].

  2019cites this paper
• Diuretic Resistance and Chronic Heart Failure

  2019cites this paper
• Relation between prognostic impact of hyperuricemia and sympathetic overactivation in patients with heart failure.

  2019cites this paper
• Effects of Weight Loss in Outpatients With Mild Chronic Heart Failure: Findings From the J-MELODIC Study.

  2019cites this paper
• Comparative effectiveness of loop diuretics on mortality in the treatment of patients with chronic heart failure - A multicenter propensity score matched analysis.

  2019cites this paper
• Impact of short-acting loop diuretic doses and cardiac sympathetic nerve abnormalities on outcomes of patients with reduced left ventricular function

  2019cites this paper
• READY: relative efficacy of loop diuretics in patients with chronic systolic heart failure—a systematic review and network meta-analysis of randomised trials

  2019cites this paper
• Comparison of Long-Acting and Short-Acting Loop Diuretics in the Treatment of Heart Failure With Preserved Ejection Fraction

  2019cites this paper
• Incidence of hospital-acquired hyponatremia by the dose and type of diuretics among patients with acute heart failure and its association with long-term outcomes.

  2018cites this paper
• Prognostic factors for long-term outcomes in acute decompensated heart failure patients under tolvaptan treatment

  2018cites this paper
• Prognostic value of hypochloremia versus hyponatremia among patients with chronic kidney disease-a retrospective cohort study.

  2018cites this paper
• Captopril Attenuates Cardiovascular and Renal Disease in a Rat Model of Heart Failure With Preserved Ejection Fraction

  2018cites this paper
• Changes in brain natriuretic peptide in chronic heart failure patients treated with long-acting versus short-acting loop diuretics: J-MELODIC subanalysis

  2017cites this paper
• Pharmacological Treatment of Heart Failure with Preserved Ejection Fraction.

  2017cites this paper
• Usefulness of the Combination of In-Hospital Poor Diuretic Response and Systemic Congestion to Predict Future Cardiac Events in Patients With Acute Decompensated Heart Failure.

  2017cites this paper
• Effects of Long-Acting Loop Diuretics in Heart Failure With Reduced Ejection Fraction Patients With Cardiac Resynchronization Therapy.

  2017cites this paper
• Pathophysiology of cardiorenal syndrome in patients with heart failure: potential therapeutic targets.

  2017cites this paper
• Comparative effects of long and short-acting loop diuretics on mortality in patients with chronic heart failure.

  2017cites this paper
• Tolvaptan Reduces the Risk of Worsening Renal Function in Patients With Acute Decompensated Heart Failure and Preserved Left Ventricular Ejection Fraction　- Prospective Randomized Controlled Study.

  2017cites this paper
• The prognostic value of brain natriuretic peptide in patients with heart failure and left ventricular ejection fraction higher than 60%: a sub‐analysis of the J‐MELODIC study

  2017cites this paper
• Comparative effects of long-acting and short-acting loop diuretics on cardiac sympathetic nerve activity in patients with chronic heart failure

  2016cites this paper
• Prognostic Impact of Loop Diuretics in Patients With Chronic Heart Failure　- Effects of Addition of Renin-Angiotensin-Aldosterone System Inhibitors and β-Blockers.

  2016cites this paper
• Sympathetic Nerve Activity Efferent Drive and Beta-Blocker Treatment　- Effect of Interaction in Systolic Heart Failure.

  2016cites this paper
• Recent Patient Characteristics and Medications at Admission and Discharge in Hospitalized Patients With Heart Failure

  2015cites this paper
• Diuretic Therapy in Heart Failure - Current Approaches.

  2015cites this paper
• Volume Overload in Heart Failure: An Evidence-Based Review of Strategies for Treatment and Prevention.

  2015cites this paper
• Chapter 21 - Diuretics

  2014cites this paper
• Diuretics in the treatment of hypertension. Part 2: loop diuretics and potassium-sparing agents

  2014cites this paper
• Clinical scenario 1 is associated with winter onset of acute heart failure.

  2014cites this paper
• Diuretics

  2014cites this paper
• Novel diuretic strategies for the treatment of heart failure in Japan.

  2014cites this paper
• The Fontan Operation Starts With the Cavopulmonary Shunt

  2013cites this paper
• The fontan operation starts with the cavopulmonary shunt.

  2013cites this paper
• Leki moczopędne w przewlekłej niewydolności serca — udokumentowane fakty i nowe zapytania

  2013cites this paper
• Medication Management of Chronic Heart Failure in Older Adults

  2013cites this paper
• Dominance of furosemide for loop diuretic therapy in heart failure: time to revisit the alternatives?

  2013cites this paper
• Cardiorenal Syndrome in Heart Failure

  2013influential citation